Suppr超能文献

基于螺吡喃的药物递送系统

Spiropyran-Based Drug Delivery Systems.

作者信息

Fagan Andrew, Bartkowski Michał, Giordani Silvia

机构信息

School of Chemical Sciences, Dublin City University (DCU), Dublin, Ireland.

出版信息

Front Chem. 2021 Jul 29;9:720087. doi: 10.3389/fchem.2021.720087. eCollection 2021.

Abstract

Nanocarriers are rapidly growing in popularity in the field of drug delivery. The ability of nanocarriers to encapsulate and distribute poorly soluble drugs while minimising their undesired effects is significantly advantageous over traditional drug delivery. Nanocarriers can also be decorated with imaging moieties and targeting agents, further incrementing their functionality. Of recent interest as potential nanocarriers are spiropyrans; a family of photochromic molecular switches. Due to their multi-responsiveness to endo- and exogenous stimuli, and their intrinsic biocompatibility, they have been utilised in various drug delivery systems (DDSs) to date. In this review, we provide an overview of the developments in spiropyran-based DDSs. The benefits and drawbacks of utilising spiropyrans in drug delivery are assessed and an outline of spiropyran-based drug delivery systems is presented.

摘要

纳米载体在药物递送领域正迅速受到欢迎。纳米载体能够包封和递送难溶性药物,同时将其不良影响降至最低,这比传统药物递送具有显著优势。纳米载体还可以用成像部分和靶向剂进行修饰,进一步增强其功能。作为潜在的纳米载体,近来备受关注的是螺吡喃;它是一类光致变色分子开关。由于它们对内源性和外源性刺激具有多重响应性,以及其固有的生物相容性,迄今为止它们已被应用于各种药物递送系统(DDS)。在本综述中,我们概述了基于螺吡喃的药物递送系统的发展情况。评估了在药物递送中使用螺吡喃的优缺点,并介绍了基于螺吡喃的药物递送系统的概况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a643/8358077/6d1f51348945/fchem-09-720087-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验